Holen Sie sich die Stockscreener-App
9.37
2.19%
-0.21
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt AVXL?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$9.58
Offen:
$9.52
24-Stunden-Volumen:
713.83K
Relative Volume:
0.70
Marktkapitalisierung:
$804.83M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-48.17M
KGV:
-16.44
EPS:
-0.57
Netto-Cashflow:
$-37.10M
1W Leistung:
-0.32%
1M Leistung:
-13.08%
6M Leistung:
+5.28%
1J Leistung:
+79.85%
1-Tages-Spanne:
$9.33
$9.685
1-Wochen-Bereich:
$8.82
$10.40
52-Wochen-Spanne:
$5.03
$14.44
Anavex Life Sciences Corporation Stock (AVXL) Company Profile
Firmenname
Anavex Life Sciences Corporation
Sektor
Branche
Telefon
844-689-3939
Adresse
630 5TH AVENUE, NEW YORK
Vergleichen Sie AVXL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corporation
|
9.37 | 762.31M | 0 | -48.17M | -37.10M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-12-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-23 | Eingeleitet | Berenberg | Buy |
| 2021-09-23 | Eingeleitet | BTIG Research | Buy |
| 2020-12-16 | Bestätigt | H.C. Wainwright | Buy |
| 2020-09-28 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2020-02-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-18 | Eingeleitet | Janney | Buy |
| 2018-05-16 | Fortgesetzt | Maxim Group | Buy |
| 2018-03-08 | Eingeleitet | ROTH Capital | Buy |
| 2018-02-13 | Bestätigt | Maxim Group | Buy |
| 2017-09-29 | Fortgesetzt | Noble Financial | Buy |
| 2017-02-07 | Eingeleitet | Noble Financial | Buy |
| 2016-03-29 | Eingeleitet | FBR Capital | Outperform |
Alle ansehen
Anavex Life Sciences Corporation Aktie (AVXL) Neueste Nachrichten
Anavex Life Sciences Stock Rises After Experimental Alzheimer’s Drug Slows Cognitive Decline In Study - MSN
Anavex Life Sciences (NASDAQ:AVXL) Trading Down 4.8%Here's What Happened - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) Given Buy Rating at HC Wainwright - MarketBeat
D. Boral Capital Reaffirms "Buy" Rating for Anavex Life Sciences (NASDAQ:AVXL) - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) Stock Price Up 9%Here's What Happened - MarketBeat
Breakeven On The Horizon For Anavex Life Sciences Corp. (NASDAQ:AVXL) - 富途牛牛
Will Anavex Life Sciences Corp. bounce back from current supportChart Signals & Safe Entry Point Alerts - Newser
Using portfolio simulators with Anavex Life Sciences Corp. included2025 Big Picture & Technical Entry and Exit Alerts - Newser
Anavex Life Sciences at H.C. Wainwright: Strategic Developments in Alzheimer’s - Investing.com
What MACD signals say about Anavex Life Sciences Corp.July 2025 Momentum & Free Expert Approved Momentum Trade Ideas - Newser
Anavex Life Sciences out with New Drug to Fight Effects of Aging - Baystreet.ca
Anavex Life Sciences Corp. Announces Oral Blarcamesine Cognitive Resilience Results Approximating Normal Aging in New Precision Medicine Clinical Data from Phase IIb/III Alzheimer's Disease Trial - MarketScreener
Anavex Life Sciences Reports Groundbreaking 48-Week Cognitive Stability Results for Blarcamesine in Early Alzheimer's Disease Treatment - Quiver Quantitative
Anavex: Oral Blarcamesine shows cognitive resilience near normal aging in Alzheimer's trial - MarketScreener
84.7% Cognitive Protection: Anavex's Oral Drug Matches Normal Aging in Landmark Alzheimer's Trial - Stock Titan
Is Anavex Life Sciences Corp.’s growth already priced inQuarterly Performance Summary & Comprehensive Market Scan Insights - beatles.ru
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q3 2025 Earnings Call Transcript - MSN
Anavex Life Sciences Corp. stock trend forecastJuly 2025 News Drivers & Real-Time Buy Signal Alerts - Newser
Has Anavex Life Sciences Corp. found a price floor2025 Growth vs Value & Daily Momentum Trading Reports - Newser
What is the earnings history of Anavex Life Sciences Corp.Quarterly Trade Review & Weekly Setup with ROI Potential - خودرو بانک
Anavex Life Sciences Corp. $AVXL Shares Purchased by Rafferty Asset Management LLC - MarketBeat
How to track smart money flows in Anavex Life Sciences Corp.M&A Rumor & Risk Managed Investment Entry Signals - Newser
Using data tools to time your Anavex Life Sciences Corp. exitTrade Volume Report & Long-Term Safe Investment Ideas - Newser
How institutional ownership impacts Anavex Life Sciences Corp. stockTrade Entry Report & Accurate Technical Buy Alerts - Newser
Sector ETF performance correlation with Anavex Life Sciences Corp.Portfolio Performance Report & Real-Time Stock Movement Alerts - Newser
Pattern recognition hints at Anavex Life Sciences Corp. upside2025 Price Momentum & Reliable Trade Execution Plans - Newser
Anavex Life Sciences Corp. stock volume spike explainedMarket Activity Report & Consistent Profit Trading Strategies - Newser
Is this a good reentry point in Anavex Life Sciences Corp.2025 Market Sentiment & Fast Moving Stock Trade Plans - Newser
Trend analysis for Anavex Life Sciences Corp. this weekPortfolio Update Summary & Reliable Intraday Trade Plans - Newser
Price action breakdown for Anavex Life Sciences Corp.July 2025 Chart Watch & Safe Entry Point Identification - Newser
Using data models to predict Anavex Life Sciences Corp. stock movementEarnings Overview Summary & Expert Approved Momentum Ideas - Newser
What does recent volatility data suggest for Anavex Life Sciences Corp.Portfolio Gains Summary & Expert Curated Trade Setups - Newser
How is Anavex Life Sciences Corp. managing supply chain issuesWeekly Stock Summary & Free Technical Confirmation Trade Alerts - خودرو بانک
Using Bollinger Bands to evaluate Anavex Life Sciences Corp.July 2025 Short Interest & Entry Point Confirmation Alerts - Newser
Multi asset correlation models including Anavex Life Sciences Corp.Day Trade & Community Consensus Trade Alerts - Newser
Chart based analysis of Anavex Life Sciences Corp. trendsGlobal Markets & Risk Managed Investment Signals - Newser
Is Anavex Life Sciences Corp. stock poised for growth2025 Historical Comparison & Long-Term Capital Growth Strategies - Newser
Price momentum metrics for Anavex Life Sciences Corp. explainedJuly 2025 Outlook & Growth Oriented Trade Recommendations - Newser
Statistical indicators supporting Anavex Life Sciences Corp.’s strength2025 Macro Impact & AI Forecasted Stock Moves - Newser
Published on: 2025-09-03 23:07:21 - Newser
How to use Fibonacci retracement on Anavex Life Sciences Corp.Market Activity Recap & Free Weekly Chart Analysis and Trade Guides - Newser
Sentiment analysis tools applied to Anavex Life Sciences Corp.Bond Market & Weekly Momentum Stock Picks - Newser
Is Anavex Life Sciences Corp. forming a double bottom2025 Performance Recap & Low Volatility Stock Suggestions - خودرو بانک
Anavex Life Sciences Corp. stock outlook for YEAR2025 Earnings Impact & High Conviction Trade Alerts - Newser
What’s the beta of Anavex Life Sciences Corp. stockJuly 2025 Price Swings & Weekly Chart Analysis and Trade Guides - خودرو بانک
Using R and stats models for Anavex Life Sciences Corp. forecasting2025 Short Interest & Advanced Swing Trade Entry Plans - Newser
Using AI based signals to follow Anavex Life Sciences Corp.Weekly Investment Report & Free Growth Oriented Trading Recommendations - Newser
Finanzdaten der Anavex Life Sciences Corporation-Aktie (AVXL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Anavex Life Sciences Corporation-Aktie (AVXL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Thomas Steffen | Director |
Jun 05 '25 |
Option Exercise |
1.76 |
50,000 |
88,000 |
55,000 |
| MISSLING CHRISTOPHER U | President and CEO |
Mar 24 '25 |
Option Exercise |
0.92 |
500,000 |
460,000 |
1,750,210 |
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):